JD vs STRO
JD.com Inc Adr (JD) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
JD currently screens at market cap $45.56B and trailing P/E 7.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the JD and STRO stock pages for the full models.
Not investment advice.